-
Mashup Score: 39British Society for Rheumatology guideline on management of adult and juvenile onset Sjögren disease - 12 day(s) ago
Abstract. Sjögren disease (SD) is a chronic, autoimmune disease of unknown aetiology with significant impact on quality of life. Although dryness (sicca) o
Source: academic.oup.comCategories: General Medicine News, RheumatologyTweet
-
Mashup Score: 57
Take this survey powered by surveymonkey.com. Create your own surveys for free.
Source: www.surveymonkey.comCategories: General Medicine News, RheumatologyTweet-
Collating the Voice of people living with Autoimmune Diseases (CoVAD 3) Survey. We aim to understand your life so that physicians may understand healthcare interventions needed to improve those with chronic diseases. If you are >18, can you spare 15 mins? https://t.co/9noPI4U9WG https://t.co/buo7t9fFk3
-
-
Mashup Score: 39The clinical relevance of WDFY4 in autoimmune diseases in diverse ancestral populations - 1 month(s) ago
Abstract. WD repeat- and FYVE domain-containing protein 4 (WDFY4), coded by a gene on 10q11.23, is a member of the BEACH (Beige and Chediak-Higashi) domain-cont
Source: academic.oup.comCategories: General Medicine News, RheumatologyTweet-
Our latest publication - the role of WDFY4 in autoimmune diseases in diverse ancestral populations. We discuss the association with rapidly-progressive interstitial lung disease in MDA5 dermatomyositis @UoMMskResearch @ManchesterBRC @NCAresearchNHS https://t.co/lg0b9YzVoB
-
-
Mashup Score: 37
Inclusion body myositis (IBM) is a rare age-associated myopathy that generally affects people over the age of 45 years [1]. The incidence and prevalence of IBM is increasing, coincident with the increasing age of the global population. However, prevalence is likely underestimated, due in part to the fact that diagnosis currently relies heavily upon myopathologic criteria. There are no specific therapies that modify the disease course, leaving patients and clinicians with supportive treatment of this disabling disorder.
Source: www.nmd-journal.comCategories: General Medicine News, RheumatologyTweet-
Here at GCOM enjoying @NEANU_2024 presenting the new diagnostic criteria for Inclusion Body Myositis. well done James, Elie @_ENMC @ElieNaddaf3 @FBMH_UoM @NCAresearchNHS https://t.co/CygYNpBNjl https://t.co/L1fzUZuqQA
-
-
Mashup Score: 34
Inclusion body myositis (IBM) is a rare age-associated myopathy that generally affects people over the age of 45 years [1]. The incidence and prevalence of IBM is increasing, coincident with the increasing age of the global population. However, prevalence is likely underestimated, due in part to the fact that diagnosis currently relies heavily upon myopathologic criteria. There are no specific therapies that modify the disease course, leaving patients and clinicians with supportive treatment of this disabling disorder.
Source: www.nmd-journal.comCategories: General Medicine News, RheumatologyTweet-
Here at GCOM enjoying @NEANU_2024 presenting the new diagnostic criteria for Inclusion Body Myositis. well done James, Elie @_ENMC @ElieNaddaf3 @FBMH_UoM @NCAresearchNHS https://t.co/CygYNpBNjl https://t.co/L1fzUZuqQA
-
-
Mashup Score: 42
Take this survey powered by surveymonkey.com. Create your own surveys for free.
Source: www.surveymonkey.comCategories: General Medicine News, RheumatologyTweet-
Collating the Voice of people living with Autoimmune Diseases (CoVAD 3) Survey. We aim to understand your life so that physicians may understand healthcare interventions needed to improve those with chronic diseases. If you are >18, can you spare 15 mins? https://t.co/9noPI4U9WG https://t.co/buo7t9fFk3
-
-
Mashup Score: 84Chimeric antigen receptor T-Cell therapy: a new emerging landscape in autoimmune rheumatic diseases - 6 month(s) ago
Abstract. Chimeric antigen receptor T cell (CAR-T) therapy, an innovative immune cell therapy, has revolutionised the treatment landscape of haematological mali
Source: academic.oup.comCategories: General Medicine News, RheumatologyTweet-
Please read our latest review in @RheumJnl : Chimeric antigen receptor T-Cell (CAR-T) therapy: a new emerging landscape in autoimmune rheumatic diseases. Is this the future for rheumatology? @LatikaGupta_ @UoMMskResearch @ManchesterBRC @NCAresearchNHS https://t.co/2wNRkziVQR
-
-
Mashup Score: 7
Treatment of hand osteoarthritis and synovitis with 20 mg methotrexate for 6 months had a moderate but potentially clinically meaningful effect on reducing pain, providing proof of concept that methotrexate might have a role in the management of hand osteoarthritis with an inflammatory phenotype.
Source: www.thelancet.comCategories: Latest Headlines, RheumatologyTweet-
Are Rheumatologists heading towards using Methotrexate for hand osteoarthritis?: Methotrexate to treat hand osteoarthritis with synovitis (METHODS): an Australian, multisite, parallel-group, double-blind, randomised, placebo-controlled trial @TheLancet https://t.co/pRw1JV7ghb
-
-
Mashup Score: 2Epidemiology of the idiopathic inflammatory myopathies - 7 month(s) ago
The idiopathic inflammatory myopathies (IIMs) are a heterogeneous group of systemic autoimmune diseases that affect the skeletal muscles and can also involve the skin, joints, lungs and heart. The epidemiology of IIM is obscured by changing classification criteria and the inherent shortcomings of case identification using healthcare record diagnostic coding. The incidence of IIM is estimated to…
Source: www.nature.comCategories: Latest Headlines, RheumatologyTweet-
RT @pash22: Epidemiology of the idiopathic inflammatory myopathies https://t.co/2LXteJopLe via @drhectorchinoy et al https://t.co/7qJl3pZJQM
-
-
Mashup Score: 8Epidemiology of the idiopathic inflammatory myopathies - Nature Reviews Rheumatology - 7 month(s) ago
In this Review, the authors present epidemiological data relating to the idiopathic inflammatory myopathies and summarize the current understanding of the risk factors associated with these conditions, as well as highlighting areas that require further research.
Source: NatureCategories: Latest Headlines, RheumatologyTweet-
Well done to my clinical fellow, Thomas Khoo @UniofAdelaide for a landmark review in @NatRevRheumatol on #myositis with global diverse authorship: Epidemiology of the idiopathic inflammatory myopathies @UoMMskResearch @NCAresearchNHS @ManchesterBRC https://t.co/P98rnjXxyF
-
. @Elizabe06972166 presenting the latest #BSR24 @RheumatologyUK guideline on management of adult and juvenile onset #Sjogren disease https://t.co/pFlykO4bpn Lots of useful stuff. Remember the following emerge as predictors of future lymphoma development: https://t.co/b7VWDGbSkt